News Releases

Add Release to Briefcase - 

All Releases

View Summary XOMA Reports 2009 and Fourth Quarter Financial Results
Mar 11, 2010
PDF 21.9 KB Add to Briefcase
View Summary XOMA to Announce 2009 and Fourth Quarter Financial Results and Host Conference Call on March 11
Mar 4, 2010
PDF 10.4 KB Add to Briefcase
View Summary XOMA to Webcast Presentations From Two March 2010 Investment Conferences
Feb 25, 2010
PDF 10.2 KB Add to Briefcase
View Summary XOMA Initiates Phase 2b Dose-Ranging Clinical Trial of XOMA 052 in Type 2 Diabetes Patients
Feb 9, 2010
PDF 11.6 KB Add to Briefcase
View Summary XOMA Announces Presentation at BIO CEO and Investor Conference on February 9
Feb 3, 2010
PDF 10.3 KB Add to Briefcase
View Summary XOMA Announces $21 Million Underwritten Offering of Common Shares and Warrants
Feb 2, 2010
PDF 11.3 KB Add to Briefcase
View Summary XOMA Reviews Priorities for 2010 and 2009 Accomplishments
Jan 19, 2010
PDF 15.4 KB Add to Briefcase
View Summary XOMA Reports Removal of "Going Concern" Qualification
Dec 22, 2009
PDF 10.3 KB Add to Briefcase
View Summary XOMA Presents Advantages of Its Multiple Antibody Formulation Technologies at Antibody Engineering Conference
Dec 10, 2009
PDF 11.2 KB Add to Briefcase
View Summary XOMA Announces NASDAQ Matter Resolved With Letter of Reprimand
Dec 9, 2009
PDF 8.9 KB Add to Briefcase
View Summary XOMA Receives NASDAQ Determination Letter
Nov 19, 2009
PDF 9.0 KB Add to Briefcase
View Summary XOMA Appoints Jim Neal Vice President of Business Development
Nov 17, 2009
PDF 11.0 KB Add to Briefcase
View Summary XOMA 052 Selected as a Top Ten Project to Watch
Nov 12, 2009
PDF 11.0 KB Add to Briefcase
View Summary XOMA Announces Presentation at Lazard Healthcare Conference on November 18
Nov 11, 2009
PDF 10.5 KB Add to Briefcase
View Summary XOMA Reports 2009 Third Quarter Financial Results
Nov 9, 2009
PDF 26.7 KB Add to Briefcase
View Summary XOMA Expands Development Strategy for XOMA 052 to Include Cardiovascular Diseases
Nov 6, 2009
PDF 14.6 KB Add to Briefcase
View Summary Phase 2 Trial of XOMA 052 to be Initiated in Type 1 Diabetes Patients
Nov 4, 2009
PDF 14.4 KB Add to Briefcase
View Summary XOMA Granted First European Patent Covering XOMA 052
Nov 4, 2009
PDF 10.4 KB Add to Briefcase
View Summary XOMA to Announce Third Quarter 2009 Financial Results and Host Conference Call on November 9
Nov 3, 2009
PDF 10.7 KB Add to Briefcase
View Summary XOMA Signs Antibody Discovery Collaboration With Kaketsuken
Nov 3, 2009
PDF 10.9 KB Add to Briefcase
Showing 1-20 of 292 releases Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15  See Next 20